Browse All

Current Filters

CLEAR FILTER x

TITLE

Describing the Population of Patients with Prolonged Seizures: US Subgroup Results from a Global Real-world Point-in-time Study

Author:Trinka, Eugen   Walker, Matthew   Kalviainen, Reetta   Haut, Sheryl   Stern, John   Hirsch, Lawrence   Gillespie, Alexander   LeBrocq, Laura   Laloyaux, Cedric   Radunz, Olaf   Wilson, J Claire   

Session Name:P7: Epilepsy/Clinical Neurophysiology (EEG): Retrospective Studies, Systematic Reviews, and Meta-analysis 2  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P7.001  

Author Institution:Department of Neurology, Neurocritical Care, and Neurorehabilitation, Member of European Reference Network EpiCARE, Center for Cognitive Neuroscience, Christian Doppler University Hospital, Paracelsus Medical University, Salzburg, Austria  Neuroscience Institute, Center for Cognitive Neuroscience, Christian Doppler University Hospital, Paracelsus Medical University, Salzburg, Austria  Institute of Public Health, Medical Decision Making and Health Technology Assessment, University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria, Salzburg, Austria  UCL Queen Square Institute of Neurology, Department of Clinical & Experimental Epilepsy, UCL, UK, London, United Kingdom  Department of Neurology, School of Medicine, University of Eastern Finland and Kuopio Epilepsy Center, Kuopio, Finland, Kuopio, Finland  Montefiore Medical Center, Albert Einstein Center, Albert Einstein College of Medicine, NY, USA, Bronx, NY  Department of Neurology, University of California, Los Angeles, CA, USA, Los Angeles, CA  Comprehensive Epilepsy Center, Department of Neurology, Yale University, New Haven, CT, USA, New Haven, CT  Adelphi Real World, Bollington, UK, Bollington, United Kingdom  UCB, Brussels, Belgium, Brussels, Belgium  UCB, Slough, UK, Slough, United Kingdom  

Design and Rationale of TRITON-PN, a Phase Three Study to Evaluate the Efficacy of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

Design of a Phase 2a Study to Evaluate the Safety, Efficacy, and Tolerability of Intravenous Empasiprubart as an Add-On Therapy to Intravenous Efgartigimod in Adult Participants With Generalized Myasthenia Gravis

Design of Phase Three of KYSA-6, a Global Open-label, Randomized, Controlled Study of KYV-101, a Fully Human CD19 Chimeric Antigen Receptor (CAR) T-cell Therapy, Versus Ongoing Standard-of-Care (SOC) Immunosuppressive Therapy in Generalized Myasthenia Gr

Author:Mupiddi, Sri   Hunter, Michael C   Hoffmann, Sarah   Hegelmaier, Tobias   Motte, Jeremias   Gold, Ralf   Mougiakakos, Dimitrios   Schubert, Charlotte   Schreiber, Stefanie   Habib, Ali   Geis, Christian   Carbunar, Olimpia   Shroff, Sheetal   Dalakas, Marinos   Berthele, Achim   Shieh, Perry   Barboi, Alexandru   Dutra, Livia   Alsolaihim, Alanood   Needham, Edward   Norwood, Fiona   Cutter, Gary R   Hunter, Brad   Chou, Justin   Xing, Baodong   Borie, Dominic   Gehchan, Naji   Haghikia, Aiden   

Session Name:P9: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis Clinical Trials  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P9.011  

Author Institution:Stanford, CA  Intermountain Medical Center, UT  Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany  Hannover Medical School, Germany  Ruhr University Bochum, Germany  Otto von Guericke University Magdeburg, Magdeburg, Germany  University Medical Center Hamburg-Eppendorf, Germany  Otto-von-Guericke University Magdeburg, Germany  University of California, Irvine, Orange, CA  Jena University Hospital, Germany  University of Miami, Miami, FL  Houston Methodist Hospital, Houston, TX  Thomas Jefferson University, Philadelphia, PA  School of Medicine, Technical University Munich, Klinikum rechts der Isar, Dept., Muenchen, Germany  University of California Los Angeles, Los Angeles, CA  Indiana University Health, IN  Instituto do Cérebro do Hospital Israelita Albert Einstein, Brazil  King Faisal Specialist Hospital and Research Center, Saudi Arabia  University of Cambridge, United Kingdom  Kings College Hospital, United Kingdom  University of Alabama , AL  Intermountain Health, UT  Kyverna Therapeutics Inc., CA  Kyverna Therapeutics Inc., Emeryville, CA  Hannover Medical School, Hannover, Germany